Minority Health Genomics and Translational Research Bio-Repository Database (MH-GRID)-2.0

Sponsor
National Human Genome Research Institute (NHGRI) (NIH)
Overall Status
Completed
CT.gov ID
NCT02290392
Collaborator
National Heart, Lung, and Blood Institute (NHLBI) (NIH)
1,692
1
56.1
30.2

Study Details

Study Description

Brief Summary

Background:
  • High blood pressure is a common problem. It can cause heart attacks, strokes, and kidney failure. It affects African Americans more than other racial groups. Data were collected from over a thousand African Americans across the country. The data were put into a database (MH-GRID). The data were about genes, diet, sleep, body mass index. They also cover stress and access to healthy foods and parks. Researchers at NIH will study these data in new ways. They want to learn more about the connection between African Americans and high blood pressure.
Objective:
  • To study MH-GRID data to find the causes of severe high blood pressure and other cardio-metabolic problems in people of African ancestry.
Eligibility:
  • African Americans age 30 55 with severe high blood pressure were used in the MH-GRID study. No new participants will be enrolled in this study.
Design:
  • Researchers will examine data from the MH-GRID study.
Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The etiology of racial/ethnic differences in health involves dynamic interactions between

    genetic, behavioral and social-environmental determinants. Despite this, the field lacks robust

    datasets that integrate these determinants with clinical assessments in minority patient cohorts. The Minority Health Genomics and Translational Research Bio-repository Database (MHGRID) Network infrastructure facilitated the collection of biospecimens and related multidimensional data elements within a consortium of minority-serving clinics. This initiative expands the diversity of ancestral groups in national genomic medicine datasets and promises to accelerate the translation of personalized medicine into minority communities. The MH-GRID project was initiated by Dr. Gibbons (founding PI) prior to becoming an NIH investigator. The MH-GRID project has completed its participant recruitment activities, closed out its NIH funding and now represents an existing dataset and biorepository that is being transferred to NHGRI for ongoing secondary analyses. A variety of investigations will be conducted on this existing dataset. The primary outcome variables include severe hypertension and hypertension induced kidney damage. Secondary outcome variables include obesity, coronary heart disease and metabolic disease syndrome. Intervening variables include genetics, behavioral (i.e. sleep quality, health literacy, smoking, diet, body mass index), ancestry, social (i.e. socioeconomic status, racial discrimination, stress, social depreivation), biological (i.e. insulin resistance, cholesterol, inflammatory markers), and environmental (i.e. neighborhood, access to healthy foods, parks).

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    1692 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Cross-Sectional
    Official Title:
    The Minority Health Genomics and Translational Research BIo-Repository Database (MH-GRID)-2.0
    Study Start Date :
    Nov 11, 2014
    Actual Primary Completion Date :
    Jul 16, 2019
    Actual Study Completion Date :
    Jul 16, 2019

    Arms and Interventions

    Arm Intervention/Treatment
    1

    African Americans age 30-55 years with severe controlled HTN or severe resistant HTN.

    Outcome Measures

    Primary Outcome Measures

    1. To complete the original MH-GRID primary outcome analyses by defining the genetic, behavioral , and social-environmental determinants of severe hypertension and other cardio-metabolic disorders in individuals of African ancestry. [one time analysis]

      To complete the original MH-GRID primary outcome analyses by defining the genetic, behavioral , and social-environmental determinants of severe hypertension and other cardio-metabolic disorders in individuals of African ancestry.

    Secondary Outcome Measures

    1. The secondary outcome variables include obesity, coronary heart disease and metabolic disease syndrome. Intervening variables include genetics, behavioral, ancestry, social, biological, and environmental. [one time analysis]

      The secondary outcome variables include obesity, coronary heart disease and metabolic disease syndrome. Intervening variables include genetics, behavioral, ancestry, social, biological, and environmental.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    30 Years to 55 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    • INCLUSION CRITERIA:

    • The MH-GRID Project s inclusion criteria included AA age 30-55 years

    • Severe controlled HTN or severe resistant HTN.

    EXCLUSION CRITERIA:
    • Exclusion criteria involved patients with secondary forms of HTN, primary forms of kidney disease or major co-morbidities (e.g. diabetes, heart failure, end-stage renal failure, HIV, and liver disease).

    • Children <18 were not enrolled in the protocol.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 National Human Genome Research Institute (NHGRI) Bethesda Maryland United States 20892

    Sponsors and Collaborators

    • National Human Genome Research Institute (NHGRI)
    • National Heart, Lung, and Blood Institute (NHLBI)

    Investigators

    • Principal Investigator: Gary H Gibbons, M.D., National Human Genome Research Institute (NHGRI)

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    National Human Genome Research Institute (NHGRI)
    ClinicalTrials.gov Identifier:
    NCT02290392
    Other Study ID Numbers:
    • 999915011
    • 15-HG-N011
    First Posted:
    Nov 14, 2014
    Last Update Posted:
    Jul 29, 2022
    Last Verified:
    Jul 27, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by National Human Genome Research Institute (NHGRI)
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 29, 2022